CLINICAL_TRIALS
research
· 2026-03-27
Clinical Trial Update: Multiparametric Magnetic Resonance Imaging of the Prostate to Assess Disease Progression and Genomics in Patients Undergoing Active Surveillance for Prostate Cancer [NA]
Summary
A National Cancer Institute study is using multiparametric MRI and genomic profiling to evaluate disease progression in men with prostate cancer on active surve…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: National Cancer Institute (NCI) | Conditions: Prostate Cancer | NA | Status: RECRUITING